{"version":"1.0","type":"link","title":"Sintilimab plus anlotinib in later-line treatment of advanced KRAS-mutant NSCLC: a multicenter, retrospective case series.","author_name":"Su Y 외","author_url":"https://prs-insight.online/author/Su%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/96149","thumbnail_width":1200,"thumbnail_height":630}